ID   PERT_HUMAN              Reviewed;         933 AA.
AC   P07202; P09934; P09935; Q8IUL0; Q8NF94; Q8NF95; Q8NF96; Q8NF97;
AC   Q8TCI9;
DT   01-APR-1988, integrated into UniProtKB/Swiss-Prot.
DT   13-NOV-2007, sequence version 4.
DT   10-MAY-2017, entry version 217.
DE   RecName: Full=Thyroid peroxidase {ECO:0000305};
DE            Short=TPO;
DE            EC=1.11.1.8 {ECO:0000250|UniProtKB:P09933};
DE   Flags: Precursor;
GN   Name=TPO {ECO:0000312|HGNC:HGNC:12015};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND VARIANTS PRO-725
RP   AND ALA-847.
RX   PubMed=3475693; DOI=10.1073/pnas.84.16.5555;
RA   Kimura S., Kotani T., McBride O.W., Umeki K., Hirai K., Nakayama T.,
RA   Ohtaki S.;
RT   "Human thyroid peroxidase: complete cDNA and protein sequence,
RT   chromosome mapping, and identification of two alternately spliced
RT   mRNAs.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:5555-5559(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS PRO-725 AND
RP   ALA-847.
RC   TISSUE=Thyroid;
RX   PubMed=3453124; DOI=10.1093/nar/15.16.6735;
RA   Libert F., Ruel J., Ludgate M., Swillens S., Alexander N., Vassart G.,
RA   Dinsart C.;
RT   "Complete nucleotide sequence of the human thyroperoxidase-microsomal
RT   antigen cDNA.";
RL   Nucleic Acids Res. 15:6735-6735(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=2548579; DOI=10.1021/bi00436a054;
RA   Kimura S., Hong Y.S., Kotani T., Ohtaki S., Kikkawa F.;
RT   "Structure of the human thyroid peroxidase gene: comparison and
RT   relationship to the human myeloperoxidase gene.";
RL   Biochemistry 28:4481-4489(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Thyroid;
RX   PubMed=2308857; DOI=10.1093/nar/18.3.670;
RA   Barnett P.S., Banga J.P., Watkins J., Huang G.C., Gluckman D.R.B.,
RA   Page M.J., McGregor A.M.;
RT   "Nucleotide sequence of the alternatively spliced human thyroid
RT   peroxidase cDNA, TPO-2.";
RL   Nucleic Acids Res. 18:670-670(1990).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT SER-257.
RC   TISSUE=Thyroid;
RA   Rapoport B.;
RL   Submitted (APR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5), AND VARIANTS SER-257; PRO-725
RP   AND ALA-847.
RC   TISSUE=Thyroid;
RA   Hennen G.P., Igout A., Melen L.B.;
RT   "Homo sapiens thyroid peroxidase (TPO) variant mRNA, alternatively
RT   spliced sequence.";
RL   Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 4; 5; 6; 2-3 AND 2-4),
RP   AND VARIANTS PRO-725 AND ALA-847.
RC   TISSUE=Thyroid;
RX   PubMed=12454013; DOI=10.1074/jbc.M209513200;
RA   Ferrand M., Le Fourn V., Franc J.-L.;
RT   "Increasing diversity of human thyroperoxidase generated by
RT   alternative splicing. Characterization by molecular cloning of new
RT   transcripts with single- and multispliced mRNAs.";
RL   J. Biol. Chem. 278:3793-3800(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 217-496.
RX   PubMed=3654979; DOI=10.1172/JCI113181;
RA   Seto P., Hirayu H., Magnusson R.P., Gestautas J., Portmann L.,
RA   Degroot L.J., Rapoport B.;
RT   "Isolation of a complementary DNA clone for thyroid microsomal
RT   antigen. Homology with the gene for thyroid peroxidase.";
RL   J. Clin. Invest. 80:1205-1208(1987).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 670-933 (ISOFORM 3), AND ALTERNATIVE
RP   SPLICING IN GRAVES' DISEASE.
RC   TISSUE=Thyroid;
RX   PubMed=2383265; DOI=10.1016/0006-291X(90)92152-P;
RA   Zanelli E., Henry M., Charvet B., Malthiery Y.;
RT   "Evidence for an alternate splicing in the thyroperoxidase messenger
RT   from patients with Graves' disease.";
RL   Biochem. Biophys. Res. Commun. 170:735-741(1990).
RN   [10]
RP   INTERACTION WITH DUOX1; DUOX2 AND CYBA.
RX   PubMed=15561711; DOI=10.1074/jbc.M407709200;
RA   Wang D., De Deken X., Milenkovic M., Song Y., Pirson I., Dumont J.E.,
RA   Miot F.;
RT   "Identification of a novel partner of duox: EFP1, a thioredoxin-
RT   related protein.";
RL   J. Biol. Chem. 280:3096-3103(2005).
RN   [11]
RP   VARIANTS TDH2A ASP-453; SER-590 AND LYS-799, AND VARIANTS SER-257;
RP   SER-373; THR-398 AND PRO-725.
RX   PubMed=7550241; DOI=10.1002/humu.1380060104;
RA   Bikker H., Vulsma T., Baas F., de Vijlder J.J.M.;
RT   "Identification of five novel inactivating mutations in the human
RT   thyroid peroxidase gene by denaturing gradient gel electrophoresis.";
RL   Hum. Mutat. 6:9-16(1995).
RN   [12]
RP   VARIANT TDH2A PHE-447.
RX   PubMed=9024270; DOI=10.1210/jcem.82.2.3729;
RA   Bikker H., Baas F., De Vijlder J.J.M.;
RT   "Molecular analysis of mutated thyroid peroxidase detected in patients
RT   with total iodide organification defects.";
RL   J. Clin. Endocrinol. Metab. 82:649-653(1997).
RN   [13]
RP   VARIANT TDH2A GLU-660.
RX   PubMed=10468986; DOI=10.1046/j.1365-2265.1999.00746.x;
RA   Santos C.L.S., Bikker H., Rego K.G.M., Nascimento A.C., Tambascia M.,
RA   De Vijlder J.J.M., Medeiros-Neto G.;
RT   "A novel mutation in the TPO gene in goitrous hypothyroid patients
RT   with iodide organification defect.";
RL   Clin. Endocrinol. (Oxf.) 51:165-172(1999).
RN   [14]
RP   VARIANTS TDH2A GLN-648 AND LYS-799.
RX   PubMed=10084596; DOI=10.1210/jcem.84.3.5541;
RA   Pannain S., Weiss R.E., Jackson C.E., Dian D., Beck J.C.,
RA   Sheffield V.C., Cox N., Refetoff S.;
RT   "Two different mutations in the thyroid peroxidase gene of a large
RT   inbred Amish kindred: power and limits of homozygosity mapping.";
RL   J. Clin. Endocrinol. Metab. 84:1061-1071(1999).
RN   [15]
RP   VARIANT TDH2A ASN-240, AND CHARACTERIZATION OF VARIANT TDH2A ASN-240.
RX   PubMed=9924196; DOI=10.1677/joe.0.1600267;
RA   Kotani T., Umeki K., Yamamoto I., Maesaka H., Tachibana K., Ohtaki S.;
RT   "A novel mutation in the human thyroid peroxidase gene resulting in a
RT   total iodide organification defect.";
RL   J. Endocrinol. 160:267-273(1999).
RN   [16]
RP   VARIANTS TDH2A THR-326; PHE-447; ASP-453; CYS-527; TRP-693 AND
RP   LYS-799.
RX   PubMed=11061528; DOI=10.1210/jcem.85.10.6878;
RA   Bakker B., Bikker H., Vulsma T., de Randamie J.S.E., Wiedijk B.M.,
RA   De Vijlder J.J.M.;
RT   "Two decades of screening for congenital hypothyroidism in The
RT   Netherlands: TPO gene mutations in total iodide organification defects
RT   (an update).";
RL   J. Clin. Endocrinol. Metab. 85:3708-3712(2000).
RN   [17]
RP   VARIANTS TDH2A PRO-458 AND HIS-491.
RX   PubMed=11415848; DOI=10.1530/eje.0.1450019;
RA   Ambrugger P., Stoeva I., Biebermann H., Torresani T., Leitner C.,
RA   Grueters A.;
RT   "Novel mutations of the thyroid peroxidase gene in patients with
RT   permanent congenital hypothyroidism.";
RL   Eur. J. Endocrinol. 145:19-24(2001).
RN   [18]
RP   VARIANTS TDH2A TRP-665 AND ARG-771, AND CHARACTERIZATION OF VARIANTS
RP   TDH2A TRP-665 AND ARG-771.
RX   PubMed=11916616; DOI=10.1530/eje.0.1460491;
RA   Umeki K., Kotani T., Kawano J., Suganuma T., Yamamoto I., Aratake Y.,
RA   Furujo M., Ichiba Y.;
RT   "Two novel missense mutations in the thyroid peroxidase gene, R665W
RT   and G771R, result in a localization defect and cause congenital
RT   hypothyroidism.";
RL   Eur. J. Endocrinol. 146:491-498(2002).
RN   [19]
RP   VARIANT TDH2A PRO-53.
RX   PubMed=12213873; DOI=10.1210/jc.2002-020153;
RA   Niu D.-M., Hwang B., Chu Y.-K., Liao C.-J., Wang P.-L., Lin C.-Y.;
RT   "High prevalence of a novel mutation (2268 insT) of the thyroid
RT   peroxidase gene in Taiwanese patients with total iodide organification
RT   defect, and evidence for a founder effect.";
RL   J. Clin. Endocrinol. Metab. 87:4208-4212(2002).
RN   [20]
RP   VARIANTS TDH2A SER-493 AND TYR-796.
RX   PubMed=11874711; DOI=10.1677/joe.0.1720627;
RA   Wu J.-Y., Shu S.-G., Yang C.-F., Lee C.-C., Tsai F.-J.;
RT   "Mutation analysis of thyroid peroxidase gene in Chinese patients with
RT   total iodide organification defect: identification of five novel
RT   mutations.";
RL   J. Endocrinol. 172:627-635(2002).
RN   [21]
RP   VARIANT TDH2A ILE-839.
RX   PubMed=12490071; DOI=10.1089/105072502320908277;
RA   Calaciura F., Miscio G., Coco A., Leonardi D., Cisternino C.,
RA   Regalbuto C., Bozzali M., Maiorana R., Ranieri A., Carta A.,
RA   Buscema M., Trischitta V., Sava L., Tassi V.;
RT   "Genetics of specific phenotypes of congenital hypothyroidism: a
RT   population-based approach.";
RL   Thyroid 12:945-951(2002).
RN   [22]
RP   VARIANTS TDH2A CYS-533 AND ASP-574-575-LEU DEL, AND CHARACTERIZATION
RP   OF VARIANTS TDH2A CYS-533 AND ASP-574-575-LEU DEL.
RX   PubMed=12864797; DOI=10.1046/j.1365-2265.2003.01823.x;
RA   Kotani T., Umeki K., Kawano J., Suganuma T., Hishinuma A., Ieiri T.,
RA   Harada S.;
RT   "Partial iodide organification defect caused by a novel mutation of
RT   the thyroid peroxidase gene in three siblings.";
RL   Clin. Endocrinol. (Oxf.) 59:198-206(2003).
RN   [23]
RP   VARIANTS TDH2A THR-307; MET-433; LEU-499 AND ARG-808.
RX   PubMed=12938097; DOI=10.1002/humu.9175;
RA   Rivolta C.M., Esperante S.A., Gruneiro-Papendieck L., Chiesa A.,
RA   Moya C.M., Domene S., Varela V., Targovnik H.M.;
RT   "Five novel inactivating mutations in the thyroid peroxidase gene
RT   responsible for congenital goiter and iodide organification defect.";
RL   Hum. Mutat. 22:259-259(2003).
RN   [24]
RP   VARIANT TDH2A TRP-693.
RX   PubMed=12843174; DOI=10.1210/jc.2002-021377;
RA   Fugazzola L., Cerutti N., Mannavola D., Vannucchi G., Fallini C.,
RA   Persani L., Beck-Peccoz P.;
RT   "Monoallelic expression of mutant thyroid peroxidase allele causing
RT   total iodide organification defect.";
RL   J. Clin. Endocrinol. Metab. 88:3264-3271(2003).
RN   [25]
RP   VARIANT TDH2A LYS-378.
RX   PubMed=16284446; DOI=10.1507/endocrj.52.643;
RA   Tajima T., Tsubaki J., Fujieda K.;
RT   "Two novel mutations in the thyroid peroxidase gene with goitrous
RT   hypothyroidism.";
RL   Endocr. J. 52:643-645(2005).
RN   [26]
RP   VARIANT TDH2A ASP-453.
RX   PubMed=16684826; DOI=10.1210/jc.2006-0142;
RA   Pfarr N., Borck G., Turk A., Napiontek U., Keilmann A.,
RA   Mueller-Forell W., Kopp P., Pohlenz J.;
RT   "Goitrous congenital hypothyroidism and hearing impairment associated
RT   with mutations in the TPO and SLC26A4/PDS genes.";
RL   J. Clin. Endocrinol. Metab. 91:2678-2681(2006).
RN   [27]
RP   VARIANTS TDH2A HIS-412 AND 596-GLU--LEU-933 DEL.
RX   PubMed=27305979; DOI=10.1038/jhg.2016.62;
RA   Mittal K., Rafiq M.A., Rafiullah R., Harripaul R., Ali H., Ayaz M.,
RA   Aslam M., Naeem F., Amin-Ud-Din M., Waqas A., So J., Rappold G.A.,
RA   Vincent J.B., Ayub M.;
RT   "Mutations in the genes for thyroglobulin and thyroid peroxidase cause
RT   thyroid dyshormonogenesis and autosomal-recessive intellectual
RT   disability.";
RL   J. Hum. Genet. 61:867-872(2016).
CC   -!- FUNCTION: Iodination and coupling of the hormonogenic tyrosines in
CC       thyroglobulin to yield the thyroid hormones T(3) and T(4).
CC       {ECO:0000250|UniProtKB:P09933}.
CC   -!- CATALYTIC ACTIVITY: 2 iodide + H(2)O(2) + 2 H(+) = diiodine + 2
CC       H(2)O. {ECO:0000250|UniProtKB:P09933}.
CC   -!- CATALYTIC ACTIVITY: [Thyroglobulin]-L-tyrosine + iodide + H(2)O(2)
CC       = [thyroglobulin]-3-iodo-L-tyrosine + 2 H(2)O.
CC       {ECO:0000250|UniProtKB:P09933}.
CC   -!- CATALYTIC ACTIVITY: [Thyroglobulin]-3-iodo-L-tyrosine + iodide +
CC       H(2)O(2) = [thyroglobulin]-3,5-diiodo-L-tyrosine + 2 H(2)O.
CC       {ECO:0000250|UniProtKB:P09933}.
CC   -!- CATALYTIC ACTIVITY: 2 [thyroglobulin]-3,5-diiodo-L-tyrosine +
CC       H(2)O(2) = [thyroglobulin]-L-thyroxine + [thyroglobulin]-
CC       aminoacrylate + 2 H(2)O. {ECO:0000250|UniProtKB:P09933}.
CC   -!- CATALYTIC ACTIVITY: [Thyroglobulin]-3-iodo-L-tyrosine +
CC       [thyroglobulin]-3,5-diiodo-L-tyrosine + H(2)O(2) =
CC       [thyroglobulin]-3,5,3'-triiodo-L-thyronine + [thyroglobulin]-
CC       aminoacrylate + 2 H(2)O. {ECO:0000250|UniProtKB:P09933}.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00298};
CC       Note=Binds 1 Ca(2+) ion per heterodimer. {ECO:0000255|PROSITE-
CC       ProRule:PRU00298};
CC   -!- COFACTOR:
CC       Name=heme b; Xref=ChEBI:CHEBI:60344;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00298};
CC       Note=Binds 1 heme b (iron(II)-protoporphyrin IX) group covalently
CC       per heterodimer. {ECO:0000255|PROSITE-ProRule:PRU00298};
CC   -!- PATHWAY: Hormone biosynthesis; thyroid hormone biosynthesis.
CC   -!- SUBUNIT: Interacts with DUOX1, DUOX2 and CYBA.
CC       {ECO:0000269|PubMed:15561711}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- SUBCELLULAR LOCATION: Isoform 3: Cell surface.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1; Synonyms=TPO1;
CC         IsoId=P07202-1; Sequence=Displayed;
CC       Name=2; Synonyms=TPO2;
CC         IsoId=P07202-2; Sequence=VSP_004665;
CC         Note=Lacks exon 10. Found in normal thyroid tissues as well as
CC         Graves'tissues. Rapidly degraded after synthesis, does not reach
CC         the cell surface. Inactive.;
CC       Name=3; Synonyms=TPO3, Graves' disease, TPOzaninelli;
CC         IsoId=P07202-3; Sequence=VSP_004666;
CC         Note=Lacks exon 16. Found in normal thyroid tissues as well as
CC         Graves'tissues. Active.;
CC       Name=4; Synonyms=TPO4;
CC         IsoId=P07202-4; Sequence=VSP_007269;
CC         Note=Lacks exon 14. Active.;
CC       Name=5; Synonyms=TPO5;
CC         IsoId=P07202-5; Sequence=VSP_007268;
CC         Note=Lacks exon 8. Does not fold correctly. Does not reach the
CC         cell surface.;
CC       Name=6; Synonyms=TPO6;
CC         IsoId=P07202-6; Sequence=VSP_004665, VSP_007270;
CC         Note=Lacks exons 10, 12, 13, 14 and 16.;
CC       Name=2-3;
CC         IsoId=P07202-7; Sequence=VSP_004665, VSP_004666;
CC         Note=Lacks exons 10 and 16.;
CC       Name=2-4;
CC         IsoId=P07202-8; Sequence=VSP_004665, VSP_007269;
CC         Note=Lacks exons 10 and 14.;
CC   -!- PTM: Glycosylated.
CC   -!- PTM: Heme is covalently bound through a H(2)O(2)-dependent
CC       autocatalytic process. Heme insertion is important for the
CC       delivery of protein at the cell surface.
CC   -!- PTM: Cleaved in its N-terminal part.
CC   -!- DISEASE: Note=An alternative splicing in the thyroperoxidase mRNA
CC       can cause Graves' disease.
CC   -!- DISEASE: Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500]: A
CC       disorder due to defective conversion of accumulated iodide to
CC       organically bound iodine. The iodide organification defect can be
CC       partial or complete. {ECO:0000269|PubMed:10084596,
CC       ECO:0000269|PubMed:10468986, ECO:0000269|PubMed:11061528,
CC       ECO:0000269|PubMed:11415848, ECO:0000269|PubMed:11874711,
CC       ECO:0000269|PubMed:11916616, ECO:0000269|PubMed:12213873,
CC       ECO:0000269|PubMed:12490071, ECO:0000269|PubMed:12843174,
CC       ECO:0000269|PubMed:12864797, ECO:0000269|PubMed:12938097,
CC       ECO:0000269|PubMed:16284446, ECO:0000269|PubMed:16684826,
CC       ECO:0000269|PubMed:27305979, ECO:0000269|PubMed:7550241,
CC       ECO:0000269|PubMed:9024270, ECO:0000269|PubMed:9924196}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the peroxidase family. XPO subfamily.
CC       {ECO:0000255|PROSITE-ProRule:PRU00298}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Thyroid peroxidase entry;
CC       URL="https://en.wikipedia.org/wiki/Thyroid_peroxidase";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J02969; AAA61215.1; -; mRNA.
DR   EMBL; J02970; AAA61216.1; -; mRNA.
DR   EMBL; Y00406; CAA68467.1; -; mRNA.
DR   EMBL; M25715; AAA97517.1; -; Genomic_DNA.
DR   EMBL; M25702; AAA97517.1; JOINED; Genomic_DNA.
DR   EMBL; M25703; AAA97517.1; JOINED; Genomic_DNA.
DR   EMBL; M25704; AAA97517.1; JOINED; Genomic_DNA.
DR   EMBL; M25705; AAA97517.1; JOINED; Genomic_DNA.
DR   EMBL; M25706; AAA97517.1; JOINED; Genomic_DNA.
DR   EMBL; M25707; AAA97517.1; JOINED; Genomic_DNA.
DR   EMBL; M25708; AAA97517.1; JOINED; Genomic_DNA.
DR   EMBL; M25709; AAA97517.1; JOINED; Genomic_DNA.
DR   EMBL; M25710; AAA97517.1; JOINED; Genomic_DNA.
DR   EMBL; M25711; AAA97517.1; JOINED; Genomic_DNA.
DR   EMBL; M25712; AAA97517.1; JOINED; Genomic_DNA.
DR   EMBL; M25713; AAA97517.1; JOINED; Genomic_DNA.
DR   EMBL; M25714; AAA97517.1; JOINED; Genomic_DNA.
DR   EMBL; X17358; CAA35235.1; -; mRNA.
DR   EMBL; M17755; AAA61217.2; -; mRNA.
DR   EMBL; AF439430; AAL74416.1; -; mRNA.
DR   EMBL; AF533528; AAN04471.1; -; mRNA.
DR   EMBL; AY136822; AAN11302.1; -; mRNA.
DR   EMBL; AF533529; AAN04472.1; -; mRNA.
DR   EMBL; AF533530; AAN04473.1; -; mRNA.
DR   EMBL; AF533531; AAN04474.1; -; mRNA.
DR   EMBL; M55702; AAA61219.1; -; mRNA.
DR   EMBL; M55702; AAA61218.1; -; mRNA.
DR   CCDS; CCDS1643.1; -. [P07202-1]
DR   CCDS; CCDS1644.1; -. [P07202-2]
DR   CCDS; CCDS1646.1; -. [P07202-5]
DR   PIR; A32413; OPHUIT.
DR   RefSeq; NP_000538.3; NM_000547.5. [P07202-1]
DR   RefSeq; NP_001193673.1; NM_001206744.1. [P07202-1]
DR   RefSeq; NP_001193674.1; NM_001206745.1. [P07202-2]
DR   RefSeq; NP_783650.1; NM_175719.3. [P07202-2]
DR   RefSeq; NP_783652.1; NM_175721.3. [P07202-4]
DR   RefSeq; NP_783653.1; NM_175722.3. [P07202-5]
DR   RefSeq; XP_011508683.1; XM_011510381.2. [P07202-8]
DR   UniGene; Hs.467554; -.
DR   ProteinModelPortal; P07202; -.
DR   SMR; P07202; -.
DR   STRING; 9606.ENSP00000318820; -.
DR   BindingDB; P07202; -.
DR   ChEMBL; CHEMBL1839; -.
DR   DrugBank; DB00389; Carbimazole.
DR   DrugBank; DB00509; Dextrothyroxine.
DR   DrugBank; DB00763; Methimazole.
DR   DrugBank; DB00550; Propylthiouracil.
DR   Allergome; 9554; Hom s TPO.
DR   PeroxiBase; 3318; HsTPO01.
DR   iPTMnet; P07202; -.
DR   PhosphoSitePlus; P07202; -.
DR   BioMuta; TPO; -.
DR   DMDM; 160281455; -.
DR   PaxDb; P07202; -.
DR   PeptideAtlas; P07202; -.
DR   PRIDE; P07202; -.
DR   Ensembl; ENST00000329066; ENSP00000329869; ENSG00000115705. [P07202-1]
DR   Ensembl; ENST00000345913; ENSP00000318820; ENSG00000115705. [P07202-1]
DR   Ensembl; ENST00000346956; ENSP00000263886; ENSG00000115705. [P07202-4]
DR   Ensembl; ENST00000382198; ENSP00000371633; ENSG00000115705. [P07202-5]
DR   Ensembl; ENST00000382201; ENSP00000371636; ENSG00000115705. [P07202-2]
DR   GeneID; 7173; -.
DR   KEGG; hsa:7173; -.
DR   UCSC; uc002qwr.4; human. [P07202-1]
DR   CTD; 7173; -.
DR   DisGeNET; 7173; -.
DR   GeneCards; TPO; -.
DR   H-InvDB; HIX0029848; -.
DR   HGNC; HGNC:12015; TPO.
DR   HPA; CAB009587; -.
DR   HPA; HPA007987; -.
DR   MalaCards; TPO; -.
DR   MIM; 274500; phenotype.
DR   MIM; 606765; gene.
DR   neXtProt; NX_P07202; -.
DR   OpenTargets; ENSG00000115705; -.
DR   Orphanet; 95716; Familial thyroid dyshormonogenesis.
DR   PharmGKB; PA36694; -.
DR   eggNOG; KOG2408; Eukaryota.
DR   eggNOG; ENOG410XPZ3; LUCA.
DR   GeneTree; ENSGT00550000074325; -.
DR   HOVERGEN; HBG000071; -.
DR   InParanoid; P07202; -.
DR   KO; K00431; -.
DR   OMA; CDSIPGM; -.
DR   OrthoDB; EOG091G0236; -.
DR   PhylomeDB; P07202; -.
DR   TreeFam; TF314316; -.
DR   BRENDA; 3.6.1.52; 2681.
DR   Reactome; R-HSA-209968; Thyroxine biosynthesis.
DR   UniPathway; UPA00194; -.
DR   ChiTaRS; TPO; human.
DR   GenomeRNAi; 7173; -.
DR   PRO; PR:P07202; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000115705; -.
DR   ExpressionAtlas; P07202; baseline and differential.
DR   Genevisible; P07202; HS.
DR   GO; GO:0009986; C:cell surface; IEA:UniProtKB-SubCell.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0004447; F:iodide peroxidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004601; F:peroxidase activity; IBA:GO_Central.
DR   GO; GO:0035162; P:embryonic hemopoiesis; IDA:DFLAT.
DR   GO; GO:0042446; P:hormone biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0042744; P:hydrogen peroxide catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006979; P:response to oxidative stress; IEA:InterPro.
DR   GO; GO:0006590; P:thyroid hormone generation; TAS:Reactome.
DR   CDD; cd00033; CCP; 1.
DR   Gene3D; 1.10.640.10; -; 1.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR010255; Haem_peroxidase.
DR   InterPro; IPR019791; Haem_peroxidase_animal.
DR   InterPro; IPR000436; Sushi_SCR_CCP_dom.
DR   InterPro; IPR029589; TPO.
DR   PANTHER; PTHR11475:SF89; PTHR11475:SF89; 1.
DR   Pfam; PF03098; An_peroxidase; 1.
DR   Pfam; PF07645; EGF_CA; 1.
DR   Pfam; PF00084; Sushi; 1.
DR   PRINTS; PR00457; ANPEROXIDASE.
DR   SMART; SM00032; CCP; 1.
DR   SMART; SM00181; EGF; 1.
DR   SMART; SM00179; EGF_CA; 1.
DR   SUPFAM; SSF48113; SSF48113; 1.
DR   SUPFAM; SSF57535; SSF57535; 1.
DR   PROSITE; PS00010; ASX_HYDROXYL; 1.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS50026; EGF_3; 1.
DR   PROSITE; PS01187; EGF_CA; 1.
DR   PROSITE; PS00435; PEROXIDASE_1; 1.
DR   PROSITE; PS50292; PEROXIDASE_3; 1.
DR   PROSITE; PS50923; SUSHI; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Complete proteome;
KW   Congenital hypothyroidism; Disease mutation; Disulfide bond;
KW   EGF-like domain; Glycoprotein; Heme; Hydrogen peroxide; Iron;
KW   Membrane; Metal-binding; Oxidoreductase; Peroxidase; Polymorphism;
KW   Reference proteome; Signal; Sushi; Thyroid hormones biosynthesis;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     18       {ECO:0000255}.
FT   CHAIN        19    933       Thyroid peroxidase.
FT                                /FTId=PRO_0000023662.
FT   TOPO_DOM     19    846       Extracellular. {ECO:0000255}.
FT   TRANSMEM    847    871       Helical. {ECO:0000255}.
FT   TOPO_DOM    872    933       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      740    795       Sushi. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN      796    839       EGF-like; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   ACT_SITE    239    239       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00298}.
FT   METAL       240    240       Calcium. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00298}.
FT   METAL       321    321       Calcium. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00298}.
FT   METAL       323    323       Calcium; via carbonyl oxygen.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00298}.
FT   METAL       325    325       Calcium. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00298}.
FT   METAL       327    327       Calcium. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00298}.
FT   METAL       494    494       Iron (heme axial ligand).
FT                                {ECO:0000255|PROSITE-ProRule:PRU00298}.
FT   BINDING     238    238       Heme (covalent; via 2 links).
FT                                {ECO:0000250}.
FT   BINDING     399    399       Heme (covalent; via 2 links).
FT                                {ECO:0000250}.
FT   SITE        396    396       Transition state stabilizer.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00298}.
FT   CARBOHYD    129    129       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    307    307       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    342    342       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    569    569       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    142    158       {ECO:0000250}.
FT   DISULFID    259    269       {ECO:0000250}.
FT   DISULFID    263    286       {ECO:0000250}.
FT   DISULFID    598    655       {ECO:0000250}.
FT   DISULFID    696    721       {ECO:0000250}.
FT   DISULFID    800    814       {ECO:0000250}.
FT   DISULFID    808    823       {ECO:0000250}.
FT   DISULFID    825    838       {ECO:0000250}.
FT   VAR_SEQ     274    446       Missing (in isoform 5).
FT                                {ECO:0000303|Ref.6}.
FT                                /FTId=VSP_007268.
FT   VAR_SEQ     534    590       Missing (in isoform 2, isoform 2-3,
FT                                isoform 2-4 and isoform 6).
FT                                {ECO:0000303|PubMed:2308857,
FT                                ECO:0000303|PubMed:3475693}.
FT                                /FTId=VSP_004665.
FT   VAR_SEQ     669    933       Missing (in isoform 6). {ECO:0000305}.
FT                                /FTId=VSP_007270.
FT   VAR_SEQ     796    839       Missing (in isoform 4 and isoform 2-4).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_007269.
FT   VAR_SEQ     874    933       TRTGTKSTLPISETGGGTPELRCGKHQAVGTSPQRAAAQDS
FT                                EQESAGMEGRDTHRLPRAL -> RVLGWKAGILTGCREPSE
FT                                GKVAGHCRTASCSQNHRTTLFQTQANRKSAGRLFSQHG
FT                                (in isoform 3 and isoform 2-3).
FT                                {ECO:0000303|PubMed:2383265}.
FT                                /FTId=VSP_004666.
FT   VARIANT      53     53       A -> P (in TDH2A).
FT                                {ECO:0000269|PubMed:12213873}.
FT                                /FTId=VAR_021622.
FT   VARIANT     240    240       D -> N (in TDH2A; loss of activity).
FT                                {ECO:0000269|PubMed:9924196}.
FT                                /FTId=VAR_021623.
FT   VARIANT     257    257       A -> S (in dbSNP:rs4927611).
FT                                {ECO:0000269|PubMed:7550241,
FT                                ECO:0000269|Ref.5, ECO:0000269|Ref.6}.
FT                                /FTId=VAR_006057.
FT   VARIANT     307    307       N -> T (in TDH2A).
FT                                {ECO:0000269|PubMed:12938097}.
FT                                /FTId=VAR_021624.
FT   VARIANT     326    326       A -> T (in TDH2A; dbSNP:rs371367459).
FT                                {ECO:0000269|PubMed:11061528}.
FT                                /FTId=VAR_021625.
FT   VARIANT     373    373       A -> S (in dbSNP:rs2280132).
FT                                {ECO:0000269|PubMed:7550241}.
FT                                /FTId=VAR_006058.
FT   VARIANT     378    378       E -> K (in TDH2A).
FT                                {ECO:0000269|PubMed:16284446}.
FT                                /FTId=VAR_025784.
FT   VARIANT     398    398       S -> T (in dbSNP:rs2175977).
FT                                {ECO:0000269|PubMed:7550241}.
FT                                /FTId=VAR_006059.
FT   VARIANT     412    412       R -> H (in TDH2A; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:27305979}.
FT                                /FTId=VAR_078336.
FT   VARIANT     433    433       V -> M (in TDH2A).
FT                                {ECO:0000269|PubMed:12938097}.
FT                                /FTId=VAR_021626.
FT   VARIANT     447    447       I -> F (in TDH2A; dbSNP:rs104893669).
FT                                {ECO:0000269|PubMed:11061528,
FT                                ECO:0000269|PubMed:9024270}.
FT                                /FTId=VAR_015375.
FT   VARIANT     453    453       Y -> D (in TDH2A; dbSNP:rs121908083).
FT                                {ECO:0000269|PubMed:11061528,
FT                                ECO:0000269|PubMed:16684826,
FT                                ECO:0000269|PubMed:7550241}.
FT                                /FTId=VAR_006060.
FT   VARIANT     458    458       L -> P (in TDH2A).
FT                                {ECO:0000269|PubMed:11415848}.
FT                                /FTId=VAR_021627.
FT   VARIANT     491    491       R -> H (in TDH2A; dbSNP:rs201165648).
FT                                {ECO:0000269|PubMed:11415848}.
FT                                /FTId=VAR_021628.
FT   VARIANT     493    493       G -> S (in TDH2A; dbSNP:rs778515113).
FT                                {ECO:0000269|PubMed:11874711}.
FT                                /FTId=VAR_021629.
FT   VARIANT     499    499       P -> L (in TDH2A).
FT                                {ECO:0000269|PubMed:12938097}.
FT                                /FTId=VAR_021630.
FT   VARIANT     527    527       W -> C (in TDH2A; dbSNP:rs779434941).
FT                                {ECO:0000269|PubMed:11061528}.
FT                                /FTId=VAR_021631.
FT   VARIANT     533    533       G -> C (in TDH2A; partial defect;
FT                                expression slightly lower in efficiency
FT                                and more degenerative than wild-type
FT                                enzyme). {ECO:0000269|PubMed:12864797}.
FT                                /FTId=VAR_027229.
FT   VARIANT     574    575       Missing (in TDH2A; partial defect;
FT                                expressed on the plasma membrane surface
FT                                at less than half the rate of wild-type
FT                                enzyme).
FT                                /FTId=VAR_027230.
FT   VARIANT     590    590       G -> S (in TDH2A; dbSNP:rs121908084).
FT                                {ECO:0000269|PubMed:7550241}.
FT                                /FTId=VAR_027231.
FT   VARIANT     596    933       Missing (in TDH2A; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:27305979}.
FT                                /FTId=VAR_078337.
FT   VARIANT     618    618       V -> M (in dbSNP:rs10189135).
FT                                /FTId=VAR_027232.
FT   VARIANT     648    648       R -> Q (in TDH2A; dbSNP:rs121908086).
FT                                {ECO:0000269|PubMed:10084596}.
FT                                /FTId=VAR_013138.
FT   VARIANT     660    660       Q -> E (in TDH2A; dbSNP:rs121908088).
FT                                {ECO:0000269|PubMed:10468986}.
FT                                /FTId=VAR_021632.
FT   VARIANT     665    665       R -> W (in TDH2A; fails to localize to
FT                                the plasma membrane; dbSNP:rs776742629).
FT                                {ECO:0000269|PubMed:11916616}.
FT                                /FTId=VAR_021633.
FT   VARIANT     693    693       R -> W (in TDH2A; dbSNP:rs121908087).
FT                                {ECO:0000269|PubMed:11061528,
FT                                ECO:0000269|PubMed:12843174}.
FT                                /FTId=VAR_021634.
FT   VARIANT     706    706       M -> V (in dbSNP:rs13431173).
FT                                /FTId=VAR_027233.
FT   VARIANT     725    725       T -> P (in dbSNP:rs732609).
FT                                {ECO:0000269|PubMed:12454013,
FT                                ECO:0000269|PubMed:3453124,
FT                                ECO:0000269|PubMed:3475693,
FT                                ECO:0000269|PubMed:7550241,
FT                                ECO:0000269|Ref.6}.
FT                                /FTId=VAR_006061.
FT   VARIANT     771    771       G -> R (in TDH2A; fails to localize to
FT                                the plasma membrane; dbSNP:rs138931129).
FT                                {ECO:0000269|PubMed:11916616}.
FT                                /FTId=VAR_021635.
FT   VARIANT     793    793       L -> P (in dbSNP:rs28991293).
FT                                /FTId=VAR_027234.
FT   VARIANT     796    796       D -> Y (in TDH2A).
FT                                {ECO:0000269|PubMed:11874711}.
FT                                /FTId=VAR_021636.
FT   VARIANT     799    799       E -> K (in TDH2A; dbSNP:rs121908085).
FT                                {ECO:0000269|PubMed:10084596,
FT                                ECO:0000269|PubMed:11061528,
FT                                ECO:0000269|PubMed:7550241}.
FT                                /FTId=VAR_006062.
FT   VARIANT     808    808       C -> R (in TDH2A).
FT                                {ECO:0000269|PubMed:12938097}.
FT                                /FTId=VAR_021637.
FT   VARIANT     839    839       V -> I (in TDH2A; dbSNP:rs146351101).
FT                                {ECO:0000269|PubMed:12490071}.
FT                                /FTId=VAR_027235.
FT   VARIANT     846    846       R -> W (in dbSNP:rs28913014).
FT                                /FTId=VAR_027236.
FT   VARIANT     847    847       V -> A (in dbSNP:rs1126799).
FT                                {ECO:0000269|PubMed:12454013,
FT                                ECO:0000269|PubMed:3453124,
FT                                ECO:0000269|PubMed:3475693,
FT                                ECO:0000269|Ref.6}.
FT                                /FTId=VAR_027237.
FT   CONFLICT     70     70       P -> G (in Ref. 5; AAA61217).
FT                                {ECO:0000305}.
FT   CONFLICT    354    354       A -> G (in Ref. 5 and 8). {ECO:0000305}.
FT   CONFLICT    371    371       A -> R (in Ref. 1; AAA61215/AAA61216).
FT                                {ECO:0000305}.
FT   CONFLICT    381    381       I -> N (in Ref. 5 and 8). {ECO:0000305}.
FT   CONFLICT    574    574       D -> N (in Ref. 2; CAA68467).
FT                                {ECO:0000305}.
FT   CONFLICT    732    732       W -> C (in Ref. 7; AAN11302).
FT                                {ECO:0000305}.
FT   CONFLICT    748    748       V -> M (in Ref. 2 and 7). {ECO:0000305}.
FT   CONFLICT    816    816       N -> S (in Ref. 6; AAL74416).
FT                                {ECO:0000305}.
FT   CONFLICT    872    872       R -> K (in Ref. 2 and 7). {ECO:0000305}.
SQ   SEQUENCE   933 AA;  102963 MW;  F67C5F1A4AEE0B29 CRC64;
     MRALAVLSVT LVMACTEAFF PFISRGKELL WGKPEESRVS SVLEESKRLV DTAMYATMQR
     NLKKRGILSP AQLLSFSKLP EPTSGVIARA AEIMETSIQA MKRKVNLKTQ QSQHPTDALS
     EDLLSIIANM SGCLPYMLPP KCPNTCLANK YRPITGACNN RDHPRWGASN TALARWLPPV
     YEDGFSQPRG WNPGFLYNGF PLPPVREVTR HVIQVSNEVV TDDDRYSDLL MAWGQYIDHD
     IAFTPQSTSK AAFGGGADCQ MTCENQNPCF PIQLPEEARP AAGTACLPFY RSSAACGTGD
     QGALFGNLST ANPRQQMNGL TSFLDASTVY GSSPALERQL RNWTSAEGLL RVHARLRDSG
     RAYLPFVPPR APAACAPEPG IPGETRGPCF LAGDGRASEV PSLTALHTLW LREHNRLAAA
     LKALNAHWSA DAVYQEARKV VGALHQIITL RDYIPRILGP EAFQQYVGPY EGYDSTANPT
     VSNVFSTAAF RFGHATIHPL VRRLDASFQE HPDLPGLWLH QAFFSPWTLL RGGGLDPLIR
     GLLARPAKLQ VQDQLMNEEL TERLFVLSNS STLDLASINL QRGRDHGLPG YNEWREFCGL
     PRLETPADLS TAIASRSVAD KILDLYKHPD NIDVWLGGLA ENFLPRARTG PLFACLIGKQ
     MKALRDGDWF WWENSHVFTD AQRRELEKHS LSRVICDNTG LTRVPMDAFQ VGKFPEDFES
     CDSITGMNLE AWRETFPQDD KCGFPESVEN GDFVHCEESG RRVLVYSCRH GYELQGREQL
     TCTQEGWDFQ PPLCKDVNEC ADGAHPPCHA SARCRNTKGG FQCLCADPYE LGDDGRTCVD
     SGRLPRVTWI SMSLAALLIG GFAGLTSTVI CRWTRTGTKS TLPISETGGG TPELRCGKHQ
     AVGTSPQRAA AQDSEQESAG MEGRDTHRLP RAL
//
